Every year, more than 20 million people in Europe suffer from heart disease. Lifestyle changes, drug therapies, pacemakers, defibrillators and stents can mitigate symptoms or slow the progression of disease, but none of these options can stop it. For those patients whose hearts have failed from an acute condition but have the potential to recover, ABIOMED has created technologies that can help. Every day, doctors at more than 700 hospitals around the world rely on ABIOMED's IMPELLA devices, BVS 5000, iPulse and AB5000 systems to rescue patients who need temporary heart assistance.

A pioneer in the use of mechanical cardiac intervention, ABIOMED is dedicated to help extend life and improve quality of life for patients with failing hearts.